Clinical Trial Update: A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate [Phase 4]

View source ↗

Summary

Phase 4 study evaluating safety and efficacy of ustekinumab in plaque psoriasis patients with an inadequate response to methotrexate; results were completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen-Cilag International NV | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2012-01-30